For women with ovarian cancer and a BRCA1/BRCA2 germline mutation who are interested in risk-reducing breast surgery, realistic information should be presented in an individualized way, in order to facilitate women making decisions about their own life and body. This evidence concerns the gene BRCA1 and ovarian cancer.